中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2015年
9期
681-684
,共4页
刘燕鹰%周姝含%张莉%徐丽玲%金月波%刘爱春%张霞%姚海红%贾园
劉燕鷹%週姝含%張莉%徐麗玲%金月波%劉愛春%張霞%姚海紅%賈園
류연응%주주함%장리%서려령%금월파%류애춘%장하%요해홍%가완
淋巴组织细胞增多症,嗜血细胞性%病因学%治疗%预后
淋巴組織細胞增多癥,嗜血細胞性%病因學%治療%預後
림파조직세포증다증,기혈세포성%병인학%치료%예후
Lymphohistiocytosis,hemophagocytic%Etiology%Therapy%Prognosis
目的 通过分析总结噬血细胞综合征(HPS)患者的临床及实验室特点,提高对该病的认识.方法 对象为北京大学人民医院2007至2014年收治的77例HPS患者,对77例患者的病因、临床表现、实验室特征、治疗及预后等进行分析.结果 77例患者男女比例相当,诊断HPS时年龄3个月~85岁.原发HPS 5例.继发HPS 72例,其中单纯感染28例,血液系统肿瘤25例,自身免疫病11例,另有8例病因未明.近一半HPS患者与自身免疫病或血液系统肿瘤同时诊断.临床上以高热(100%)、肝脾(81.8%)及淋巴结肿大(40.3%)为主要表现.实验室检查方面,以血细胞减少(94.8%)、铁蛋白升高(93.2%)为主,纤维蛋白原减低占61.8%,其中6例合并弥漫性血管内凝血(DIC).高甘油三酯血症占一半以上.78.1%患者可在骨髓检查中见噬血细胞现象.自然杀伤细胞活性减低或缺失占95.2%,可溶性CD25抗原(sCD)升高所占比例为100%.其他脏器损害以肺部感染(36.4%)及肝损伤(33.3%)多见.约70%患者应用激素联合依托泊苷和(或)环孢素A治疗.8例自身免疫病患者应用激素冲击治疗(甲泼尼龙200 ~ 500 mg/d).53例病情好转出院,14例死亡,10例因病情加重放弃治疗出院.此预后不良的24例中5例合并DIC,5例合并多脏器衰竭.血液系统肿瘤病死率最高(52.0%),此后依次为单纯感染(25.0%)、自身免疫病(18.2%).结论 自身免疫病和血液系统肿瘤在起病同时即可出现HPS表现,对可疑患者及时行相关实验室检查有助于早期明确诊断.合并DIC、多脏器受损的患者预后不良.
目的 通過分析總結噬血細胞綜閤徵(HPS)患者的臨床及實驗室特點,提高對該病的認識.方法 對象為北京大學人民醫院2007至2014年收治的77例HPS患者,對77例患者的病因、臨床錶現、實驗室特徵、治療及預後等進行分析.結果 77例患者男女比例相噹,診斷HPS時年齡3箇月~85歲.原髮HPS 5例.繼髮HPS 72例,其中單純感染28例,血液繫統腫瘤25例,自身免疫病11例,另有8例病因未明.近一半HPS患者與自身免疫病或血液繫統腫瘤同時診斷.臨床上以高熱(100%)、肝脾(81.8%)及淋巴結腫大(40.3%)為主要錶現.實驗室檢查方麵,以血細胞減少(94.8%)、鐵蛋白升高(93.2%)為主,纖維蛋白原減低佔61.8%,其中6例閤併瀰漫性血管內凝血(DIC).高甘油三酯血癥佔一半以上.78.1%患者可在骨髓檢查中見噬血細胞現象.自然殺傷細胞活性減低或缺失佔95.2%,可溶性CD25抗原(sCD)升高所佔比例為100%.其他髒器損害以肺部感染(36.4%)及肝損傷(33.3%)多見.約70%患者應用激素聯閤依託泊苷和(或)環孢素A治療.8例自身免疫病患者應用激素遲擊治療(甲潑尼龍200 ~ 500 mg/d).53例病情好轉齣院,14例死亡,10例因病情加重放棄治療齣院.此預後不良的24例中5例閤併DIC,5例閤併多髒器衰竭.血液繫統腫瘤病死率最高(52.0%),此後依次為單純感染(25.0%)、自身免疫病(18.2%).結論 自身免疫病和血液繫統腫瘤在起病同時即可齣現HPS錶現,對可疑患者及時行相關實驗室檢查有助于早期明確診斷.閤併DIC、多髒器受損的患者預後不良.
목적 통과분석총결서혈세포종합정(HPS)환자적림상급실험실특점,제고대해병적인식.방법 대상위북경대학인민의원2007지2014년수치적77례HPS환자,대77례환자적병인、림상표현、실험실특정、치료급예후등진행분석.결과 77례환자남녀비례상당,진단HPS시년령3개월~85세.원발HPS 5례.계발HPS 72례,기중단순감염28례,혈액계통종류25례,자신면역병11례,령유8례병인미명.근일반HPS환자여자신면역병혹혈액계통종류동시진단.림상상이고열(100%)、간비(81.8%)급림파결종대(40.3%)위주요표현.실험실검사방면,이혈세포감소(94.8%)、철단백승고(93.2%)위주,섬유단백원감저점61.8%,기중6례합병미만성혈관내응혈(DIC).고감유삼지혈증점일반이상.78.1%환자가재골수검사중견서혈세포현상.자연살상세포활성감저혹결실점95.2%,가용성CD25항원(sCD)승고소점비례위100%.기타장기손해이폐부감염(36.4%)급간손상(33.3%)다견.약70%환자응용격소연합의탁박감화(혹)배포소A치료.8례자신면역병환자응용격소충격치료(갑발니룡200 ~ 500 mg/d).53례병정호전출원,14례사망,10례인병정가중방기치료출원.차예후불량적24례중5례합병DIC,5례합병다장기쇠갈.혈액계통종류병사솔최고(52.0%),차후의차위단순감염(25.0%)、자신면역병(18.2%).결론 자신면역병화혈액계통종류재기병동시즉가출현HPS표현,대가의환자급시행상관실험실검사유조우조기명학진단.합병DIC、다장기수손적환자예후불량.
Objective To summarize the clinical features and laboratory data of 77 patients with hemophagocytic syndrome (HPS).Methods A total of 77 patients of HPS were continuously collected from 2007 to 2014 at our hospital.Their underlying diseases,clinical features,laboratory data,therapy and prognosis were analyzed.Results Their The patients aged from 3 months to 85 years.The gender ratio was roughly equal.Primary HPS was diagnosed in only 5 cases by gene detection Another 72 cases belonged to secondary HPS.The causes were infection (n =28),hematologic neoplasm (n =25),autoimmune diseases (AID,n =11) and unknown (n =8).HPS was the initial symptom in nearly half cases of hematologic neoplasm and AID.HPS was characterized by high fever (100%),hypersplenomegaly (81.8%) and lymphadenopathy (40.3%).Laboratory data showed cytopenia (94.8%),serum ferritin elevation (93.2%),hypofibrinogenemia (61.8%),hemophagocytosis in bone marrow (78.1%) and hypertriglyceridemia (55.3%).Low NK-cell activity (95.2%) and elevation of sCD25 (100%) were specific manifestations in HPS.Pulmonary infection (36.4%) and hepatic malfunction (33.3%) were common.Approximately 70% were treated with HLH-2004.Pulse-dose corticosteroid therapy (methylprdnisolone 200-500 mg/d) was used in 8 AID patients.And 14 patients died and 10 withdrew treatment because of exacerbation.Five had complications of DIC and another 5 progressed into MODS.Neoplasm (52.0%) had the highest mortality in secondary HPS.And infection (25.0%) and AID (18.2%) followed.Conclusion Sometimes HPS occurs simultaneously with autoimmune disease or neoplasm.Relevant laboratory tests for suspected patients may aid an early diagnosis.Presence of DIC or MODS in HPS is possibly correlated with a poor prognosis and a high mortality.